Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

The median age at symptom onset in the cohort was 55 years, ranging from 16 to 81 years. Data from patients’ initial ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Las acciones de las empresas farmacéuticas cayeron en todo el mundo después de que el presidente de EE.UU., Donald Trump, ...

Among the safety stocks discussed by Cramer during the episode on May 14, Bristol-Myers Squibb Company (NYSE:BMY) was first ...

Although the Trump administration's healthcare policies pose risks for Bristol-Myers Squibb, the chaos opens a contrarian door for BMY stock.

Bristol-Myers Squibb Co. prevailed against investor allegations it misled them about a payout tied to Food and Drug ...

Shares of Bristol Myers Squibb Co. BMY slipped 1.55% to $46.88 Thursday, on what proved to be an all-around positive trading ...

We recently published a list of Domestic Manufacturing Boom: 12 Best Pharma Stocks to Invest in Now. In this article, we are ...

Bristol Myers Squibb, the pharmaceutical company headquartered in New Jersey, announced plans to lay off more than 500 ...

Bristol Myers Squibb plans to cut 516 jobs in NJ as part of a $2B cost-saving initiative, bringing total layoffs this year to ...

Bristol-Myers Squibb (BMY) stock is down 11% year-to-date as the company navigates several looming patent cliffs. After a $13 ...